Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Ather's board meets June 12 to pick QIP, rights, or other instruments. The choice will reveal whether the company is accelerating growth or shoring up cash. Watch the use of proceeds.
NWXSX beat its benchmark in Q1 2026. The real test is attribution: country, currency, or stock selection. Learn what to check before deciding.
Apply the coach's focus-narrowing technique to your trading plan. Identify one pre-defined action for high-pressure moments to avoid emotional decisions.
GSK's move to acquire Nuvalent for $9-10B breaks its small-deal rule. Two FDA catalysts on Nov. 27 and for zidesamtinib define the premium.
Retired Honda executives tried to oust CEO Mibe over China and EV failures. The board backed him, removing a governance overhang but leaving the strategic gap unresolved.
Zepp Health Q1 revenue rose 33.8% to $51.55M, but Non-GAAP EPADS loss hit $1.13. The Q2 outlook now sets the stock's direction—whether growth can turn profitable.
xAI hired a Starlink engineer to lead Grok training. The bet: infrastructure execution, not research breakthroughs, will close the gap with OpenAI.
Seeking Alpha's political forum thread contains no market event. Without a catalyst or data, a risk event watch is not possible.
SEBI raises the open offer exemption threshold to 5% from 2%, altering the takeover code for promoters and activist funds building stakes without triggering a public offer.
A US judge struck down the $100,000 H-1B visa fee. Indian IT firms gain a direct margin boost. The ruling competes against persistent FII selling and crude volatility.
ACN's Song unit generated $20B in FY25, making it the world's largest ad agency. It avoids the label. Alpha Score 50 reflects the margin debate.
A 12% withdrawal rate on a Rs 1.5 crore corpus risks depletion. Three strategies – conservative, moderate, aggressive – each require a dynamic spending rule to survive.
Janus Henderson Opportunistic Alpha returned -4.62% in Q1 2026, trailing its benchmark. The drawdown signals a factor timing miss or execution friction. Watch the attribution report for the next catalyst.
NFHS-6 shows 31% of women and 27% of men now obese, while a third of children remain underweight. The agricultural supply chain, not just policy, must shift.
Medicare faces a June 15 deadline on TAVR coverage. Behind the policy: a $9M annual registry fee stream controlled by cardiology and thoracic surgery societies.
State Assemblyman Alex Bores reveals top AI firms are opposing his congressional run. The opposition signals a shift in industry political strategy with regulatory implications.
US State Department will charge USD 750 for 10-day visa interview slots starting July 1. The pilot reallocates capacity, not expanding it — standard wait times may lengthen at participating embassies.
NFL veteran Michael Brockers reopens QUAD Houston with a revamped concept, new menus, and expanded viewing areas timed to the FIFA season and Houston's sports tourism surge.
Goldman Sachs and JPMorgan explore GPU futures. Polymarket's first institutional block trade shows a working benchmark. The timeline risk is real.
Confessions Restaurant & Lounge launches a spring brunch menu with caviar toast, donut burgers, and a mimosa tree. The cocktail-heavy format targets Houston's premium weekend slot. What signals confirm the strategy is working and what it means for competitors.
Mawani's SAR 2 billion Jubail port concession with Saudi Global Ports lifts container capacity 60% to 2.4M TEUs. Deepening berths to 18m positions the terminal for ultra-large vessels, challenging regional hub ports.
Israel called off a massive third strike wave on Iran after Trump's phone intervention. Track Hezbollah rocket fire as the next trigger. Crude and petrochemical risk remains.
Cognizant published its AI Forum 2026 slide deck. The event signals a strategic push into enterprise AI. Alpha Score 42 suggests mixed sentiment. What to look for in the presentation.
SLDB CEO Alexander Cumbo presented at the Goldman Sachs healthcare conference on June 8. The transcript is now the primary signal for DMD gene therapy traders until the next data release.
OpenAI CEO Sam Altman's third-phase plan pitches abundance and safety together. The $150B IPO valuation depends on whether the S-1 numbers fit the frame.
Tandem management at Goldman Sachs conference highlighted the FDA submission timeline for a next-gen algorithm as the key catalyst. Gross margins face pressure from the Mobi ramp, while international sales growth offers a partial offset.
CMG fell 21% after a Buy-to-Hold downgrade, yet the Alpha Score stays at 26/100. The next earnings call is the only catalyst that shifts the risk/reward.
The asymmetry between slow-adapting regulation and fast-adapting capitalism creates a persistent drag on market efficiency. Here's how to monitor it.
OpenAI files confidential IPO with SEC one week after Anthropic. The $150B valuation faces a 40x revenue multiple test as two AI prospectuses arrive in quick succession.
Apple extends CPU scheduler to iPhone 11 at WWDC, delaying upgrade pressure and boosting installed base value. Next catalyst: iPhone 16 demand and services margin trajectory.